World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
A Wolfe in Regulator's Clothing: Drug Industry Critic Joins the FDA
Keywords:
Tags:
Dr. Wolfe, a drug safety critic and head of the health group of Public Citizen, a Ralph Nader founded consumer advocacy organization, has been appointed to a four year term on the FDA's Drug Safety and Risk Management Committee. Dr Wolfe's has a history as a consumer advocate for health safety and a critic of the corporate influence in FDA decisions. He would like to see fewer copycats of popular drugs and limits on direct to consumer advertising. Here Dr Wolfe's personal style as an activist is explored. He admits he tends to have firm opinions.
Dr. Sidney Wolfe of Public Citizen on FDA's Drug Safety and Risk Management Committe in 2009
01/09/2009
Wolfe is pushing for changes in the poor business practices of pharmaceutical companies.
Grouped Articles
A Wolfe in Regulator's Clothing: Drug Industry Critic Joins the FDA
Wall Street Journal 01/09/2009
FDA's Drug Safety and Risk Management Committee.
05/21/2007
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09/24/2010
BusinessWeek 05/21/2007
A Wolfe in Regulator's Clothing: Drug Industry Critic Joins the FDA
Wall Street Journal 01/09/2009
FDA's approach to approving drugs of pharmaceutical companies and weighing the risks and benefits.
07/01/2005
The questions of safety balanced by the need to let patients have access to drugs that would help them. The processes the FDA uses to arrive at proper decisions.
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09/24/2010
FDA Says Two Eczema Products To Carry Cancer-Risk Warnings
Wall Street Journal 01/20/2006
Acting FDA Chief Asserts a Need To Review Drug-Approval Process
Wall Street Journal 09/26/2005
FDA Reviews of New Drugs May Signal Tougher Scrutiny
Wall Street Journal 08/23/2005
FDA Moves Toward Harder Line on Suicide Risks
Wall Street Journal 07/01/2005
Baxter Infusion Pumps Are Target of FDA Probe
Wall Street Journal 07/22/2005
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
